|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 45/06 | |
| A61K 31/44 | |||
| A61K 31/4748 | |||
| A61P 25/28 |
| (11) | Patento numeris | 2931315 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13831902.5 |
| Europos patento paraiškos padavimo data | 2013-12-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-10-21 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-11-29 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2013/060744 |
| Data | 2013-12-09 |
| (87) | Numeris | WO 2014/091388 |
| Data | 2014-06-19 |
| (30) | Numeris | Data | Šalis |
| 201261735720 P | 2012-12-11 | US |
| (72) |
Feuerbach, Dominik, CH
Gomez-Mancilla, Baltazar, CH
HE, Yunsheng, US
Johns, Donald, US
Lopez-Lopez, Cristina, CH
MCAllister, Kevin Hall, CH
Pezous, Nicole, CH
Sandford, Lisa, CH
Weiss, Markus, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | BIOMARKER PREDICTIVE OF RESPONSIVENESS TO ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR ACTIVATOR TREATMENT |
| BIOMARKER PREDICTIVE OF RESPONSIVENESS TO ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR ACTIVATOR TREATMENT |